suggested that posttransplantation mutations on hematopoiesis–associated genes DNMT3A, TET2, and ASXL1 had no prognostic impact in patients with AML [24], dynamic evaluation of pre‐ and post‐transplant ASXL1 should be made to fully explore the prognostic effect of ASXL1 burden on allo‐HSCT. Here, DNMT3A is linked to acute myeloid leukemia.